Patent · US Active

Enone reductases

US8883475B2 · kind B2 · utility

4Cited by
9References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2012
Grant dateNov 11, 2014
Priority date
Expiry dateDec 21, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/52
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure relates to engineered enone reductase polypeptides having improved properties, polynucleotides encoding the engineered polypeptides, related vectors, host cells, and methods for making the engineered enone reductase polypeptides. The disclosure also provides methods of using the engineered enone reductase polypeptides for chemical transformations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.